Boston BioProducts Strengthens Leadership Team, Setting New Standards in Reagent Manufacturing and Quality
Boston BioProducts, a longstanding manufacturer of catalog and custom reagent solutions for the life sciences, today announced the expansion of its leadership team with the addition of Kammie McHugh as Director of Quality & Regulatory and Matt Smart as Director of Process Excellence. McHugh brings demonstrated success in building quality systems and organizations within life sciences and diagnostics, while Smart brings extensive technical expertise in optimizing manufacturing operations for life science tools and contract manufacturing companies.
“These new leadership additions will support our ongoing trajectory of growth as Boston BioProducts continues to invest across three vital segments: Research, Diagnostics, and Drug Development,” said Neil Sharma, General Manager of Boston BioProducts. “We will lean on Kammie and Matt’s expertise to help us bring forth new custom reagent offerings, implement high-throughput formulation-to-fill capabilities, and build upon our GMP manufacturing process and QC testing services.”
Earlier this year, Boston BioProducts received ISO 13485:2016 certification for its quality management system, reinforcing the company’s commitment to high-quality standards across the entire reagent manufacturing process.
Kammie McHugh brings 16 years of experience building quality and regulatory programs at Launchworks CDMO, Qiagen, Quidel, and BioHelix. She joins Boston BioProducts from MDC Associates, where she served as a quality and regulatory consultant across the biotechnology sector. Drawing from her technical background in molecular diagnostics and assay development, McHugh excels in building fit-for-purpose quality systems that address the unique needs of life science organizations.
Matt Smart joins Boston BioProducts with two decades of experience in the life sciences and diagnostics industries. He has served in leadership capacities and was instrumental in establishing operational excellence in manufacturing and quality control at organizations including Quanterix, Launchworks CDMO, Boston Analytical, Corning Life Sciences and Becton Dickinson.
About Boston BioProducts
For nearly 30 years, Boston BioProducts has manufactured and supplied fundamental reagents (buffers, solutions, media, and more) to researchers, diagnostic and technology platforms, and drug developers worldwide. With its custom reagent manufacturing services, Boston BioProducts becomes an extension of your lab with flexible parameters to design the ideal research and manufacturing tools. Its mission is to increase the reproducibility of product- and process-critical reagents that keep your science consistent and moving forward. For more information, please visit www.bostonbioproducts.com and follow us on LinkedIn.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231107736982/en/
Contact information
Kimberly Sweeney
Marketing Operations Manager
marketing@bostonbioproducts.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Perma-Pipe International Holdings, Inc. Announces Fourth Quarter and Fiscal 2024 Financial Results1.5.2025 23:24:00 EEST | Press release
Perma-Pipe International Holdings, Inc. (NASDAQ: PPIH) announced today financial results for the fourth quarter and 2024 fiscal year ended January 31, 2025. “Sales for the fourth quarter and full year 2024 show moderate growth and were $45.0 million and $158.4 million, resulting in increases of $4.8 million and $7.7 million, compared to the prior year. Income before taxes was $5.3 million and $18.5 million in the fourth quarter and for the full year 2024, which increased by $2.1 million and $8.6 million, compared to the prior year. This significant increase was a result of our focus on higher margin products and services that contributed to improved margin performance. Net income after taxes and minority interest was $1.5 million and $9.0 million in the fourth quarter and for the full year 2024. Although 2024 net income was a decrease of $1.5 million, compared to $10.5 million last year, the reduction was due to a one-time non-cash tax benefit of $5.9 million in the prior year after be
IFF Declares Dividend for Second Quarter 20251.5.2025 23:15:00 EEST | Press release
IFF (NYSE: IFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.40 per share of its common stock, payable on July 11, 2025 to shareholders of record as of June 20, 2025. Welcome to IFF At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in flavors, fragrances, food ingredients, health and biosciences, we deliver groundbreaking, sustainable innovations that elevate everyday products—advancing wellness, delighting the senses and enhancing the human experience.Learn more at iff.com, LinkedIn, Instagram and Facebook. © 2025 by International Flavors & Fragrances Inc. IFF is a Registered Trademark. All Rights Reserved. View source version on businesswire.com: https://www.businesswire.com/news/home/20250501776988/en/
Rimini Street Announces Fiscal First Quarter 2025 Financial and Operating Results1.5.2025 23:01:00 EEST | Press release
Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support and innovation solutions, and the leading third-party support provider for Oracle, SAP and VMware software, today announced results for the fiscal first quarter ended March 31, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250501664008/en/ Select First Quarter 2025 Financial Results Revenue was $104.2 million for the 2025 first quarter, a decrease of 2.4% compared to $106.7 million for the same period last year. U.S. revenue was $50.1 million for the 2025 first quarter, a decrease of 6.9% compared to $53.8 million for the same period last year. International revenue was $54.1 million for the 2025 first quarter, an increase of 2.2% compared to $52.9 million for the same period last year. Subscription revenue was $99.0 million, which accounted for 95.0% of total revenue for the 2025 first quarter, compared to subscription rev
Textron Aviation Calls on Cessna, Beechcraft and Hawker Owners to Transport Athletes to the 2026 Special Olympics USA Games1.5.2025 18:31:00 EEST | Press release
Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company, today announced the coordination of the ninth Special Olympics Airlift, a monumental event aimed at transporting hundreds of athletes and coaches across country to the 2026 Special Olympics USA Games in Minnesota’s Twin Cities. The company is calling on Cessna, Beechcraft and Hawker aircraft owners and operators to come together on Friday, June 19, 2026, and Saturday, June 27, 2026, to enable champions from all corners of the nation to travel to and from the host city, regardless of financial or logistical challenges. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250430812758/en/ Textron Aviation Inc. announced the coordination of the ninth Special Olympics Airlift, a monumental event aimed at transporting hundreds of athletes and coaches across country to the 2026 Special Olympics USA Games in Minnesota’s Twin Cities. (Photo credit: Textron Aviation) The Special Oly
Giovanni Brienza Appointed President of Frontline International1.5.2025 18:16:00 EEST | Press release
Frontline International, celebrating 25 years of innovation in commercial kitchen solutions, has appointed Giovanni Brienza as its new president. Founder John Palazzo will continue as CEO, focusing on strategic direction and long-term growth initiatives. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250501026483/en/ Giovanni Brienza, Frontline International President Frontline is a USA-based manufacturer of systems used globally by foodservice operations for safer, more sustainable fat, oil, and grease (FOG) management. The company’s automated solutions increase kitchen safety. Brienza, who joined Frontline in 2004, brings 21 years of operational expertise and engineering insight to his new role. He has been a key architect behind many of Frontline’s most impactful innovations, from equipment and software systems to strategically expanding the company’s footprint into key international markets. Under his leadership, Frontli
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom